Cancer care at the end of life: system-wide expenditure in a national health service.

ABSTRACT:

Purpose

The provision of specialized palliative care (SPC) and the timely discontinuation of cancer-targeted treatments (CTT) are increasingly considered important in cancer care at the end of life (EoL). EoL cancer care decisions are often initiated in the hospital, and little is known about associated expenditure in other parts of the health system. Our primary objective was to examine the total healthcare and care setting-specific expenditure associated with either exposure to SPC or timely discontinuation of CTT for patients with cancer in the last 4 weeks of life. Our secondary objectives were to (1) examine how these expenditures evolved in the last 4 weeks of life and across care settings and (2) explore the relation between the associated expenditures of SPC and timely disc

SUBMITTER: Hasse HT 

PROVIDER: S-EPMC12540515 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature